Global Obstructive Lung Disease Management Markets 2021: Opportunities Led by Big Pharma and Medical Device Companies and New Collaborations in Developing Affordable and Quality-Driven Treatments
23 sept. 2021 04h58 HE
|
Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Obstructive Lung Disease Management Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report provides a...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
24 août 2021 16h05 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Global Respiratory Care Medical Devices Market Report 2021-2025: Increasing Demand for Enhanced Portable Devices & Focus of Market Players to Expand Geographic Presence
28 avr. 2021 07h33 HE
|
Research and Markets
Dublin, April 28, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's...
COPD and Asthma Devices Market is anticipated to hit $51.62 billion by 2027, At CAGR 4.3%
04 nov. 2020 10h00 HE
|
Allied Market Research
Portland, OR, Nov. 04, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research the global COPD and asthma devices market size was estimated at $36.45 billion in 2019,...
Digital Therapeutics Market to Reach $9.64 Bn, Globally, by 2026: Allied Market Research
25 févr. 2020 09h34 HE
|
Allied Market Research
Portland, OR, Feb. 25, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global digital therapeutics industry generated $2.24 billion in 2018, and is...
Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care
12 nov. 2019 08h45 HE
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth...
Significant reductions in costly pulmonary complications with use of drug-free device
20 juin 2018 07h45 HE
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., June 20, 2018 (GLOBE NEWSWIRE) -- Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary...
New published evidence reinforces the importance of device choice in asthma control
31 janv. 2018 08h45 HE
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 31, 2018 (GLOBE NEWSWIRE) -- A recent article in Pulmonary Pharmacology and Physiology1 provides in vitro evidence that the AEROCHAMBER PLUS® FLOW-VU® valved holding chamber...
The Aerobika(R) Device, Marketed by Monaghan Medical in the United States, Benefits COPD Patients and Wins Gold at MDEA Awards
16 juil. 2014 14h38 HE
|
Monaghan Medical Corporation
PLATTSBURGH, NY--(Marketwired - Jul 16, 2014) - The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
10 juin 2013 02h10 HE
|
Pearl Therapeutics
Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics
Inc. today announced that it has entered into a definitive
merger agreement under which the Company will be acquired...